Form 4 holding
Corporate Controller and PFO
Armata Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 10,000
- Estimated value
- $50,000
- Report date
- 14 Mar 2024
- Price
- $5.00
- Ownership
- Direct
Richard Rychlik
Insider Reports History
- Reporting-owner location
- Los Angeles, CA
- Latest reporting-owner signature
-
/s/ Richard Rychlik
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Richard Rychlik
Form 4 holding
Corporate Controller and PFO
Armata Pharmaceuticals, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 40,000
- Estimated value
- Report date
- 14 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Richard Rychlik
4
ARMP
Armata Pharmaceuticals, Inc.
- Report period
- 14 Mar 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 18 Mar 2024, 20:02
- Role
- Corporate Controller and PFO
- Next action
- Open filing details
4
ARMP
Armata Pharmaceuticals, Inc.
- Report period
- 21 Dec 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 26 Dec 2023, 21:54
- Role
- Corporate Controller and PFO
- Next action
- Open filing details
3
ARMP
Armata Pharmaceuticals, Inc.
- Report period
- 15 Sep 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 22 Sep 2023, 19:17
- Role
- Corporate Controller and PFO
- Next action
- Open filing details